ERBB2 and triple-negative breast carcinoma: A majority of the ER, PR and HER2-negative (triple-negative breast cancers, TNBC) are molecularly subtyped as basal-like, but it is reported that there are multiple “TNBCtype”s [16], suggesting that a spectrum of subgroups exists within TNBC [17–19].